Shanghai – September 28, 2026 -- Mikala Sposito, a 21-year-old welding student from Washtenaw Community College, won a bronze medal at the 48th WorldSkills Competition, becoming the first woman to represent the United States in the Welding skill category.

Nine-member U.S. delegation competes against global field of 1,400

The 2026 WorldSkills USA team, comprising nine SkillsUSA state champions, competed Sept. 22-27 in Shanghai against skilled professionals from 73 countries and regions across 64 skill categories, including seven new emerging occupations.

Perth – September 27, 2026 -- PECHOIN, a Chinese skincare brand, is marking its 10th consecutive year of participation at the Congress of the International Federation of Societies of Cosmetic Chemists (IFSCC), presenting new research on Asian skin at what is widely regarded as the cosmetics industry's top scientific forum.

Hong Kong – September 27, 2026 -- Akeso, Inc. (9926.HK) has enrolled the first patient in COMPASSION-37, a global Phase III head-to-head trial testing its bispecific antibody cadonilimab against nivolumab as first-line treatment for HER2-negative advanced gastric and gastroesophageal junction (G/GEJ) adenocarcinoma.

Rome – September 27, 2026 -- Yili Group presented a China-based whole-value-chain dairy symbiosis model at the Food and Agriculture Organization's inaugural Global Conference for Actions on One Health in Agrifood Systems, detailing how the company restored 55,000 mu (3,667 hectares) of degraded grassland and helped 5,600,000 herders in Inner Mongolia raise incomes over more than a decade.

Shenzhen – September 27, 2026 -- Memory and storage executives from Samsung, Sandisk, Solidigm, Arm and Lenovo converged in Shenzhen on September 23 to argue that AI inference workloads, not training alone, are now the primary driver reshaping storage architecture demand. The 5th GMIF2026 Innovation Summit, co-hosted by the Shenzhen Memory Industry Association (SMIA) and Peking University's School of Integrated Circuits, drew IDMs, controller makers, OSATs, and AI infrastructure vendors under the theme "The Future Built on AI Memory and Storage."

Shanghai – September 26, 2026 -- IASO Biotechnology reported a 90% objective response rate and 90% minimal residual disease (MRD) negativity rate for its BCMA-targeted in vivo CAR-T therapy IASO206, generated via a single intravenous infusion without lymphodepleting chemotherapy, in first-in-human Phase 1 data presented as a late-breaking oral session (LBA-11) at the 2026 International Myeloma Society Annual Meeting.

Shanghai – September 26, 2026 -- IASO Biotechnology's CAR-T therapy FUCASO achieved a 95.9% objective response rate and 77.2% complete/stringent complete response rate in a real-world study of 281 heavily pretreated Chinese patients with relapsed or refractory plasma cell neoplasms, data presented at the 2026 International Myeloma Society Annual Meeting show.

NEW YORK – September 26, 2026 -- China Southern Airlines marked its 70th anniversary with a Times Square display, coinciding with the Mid-Autumn Festival, as the Guangzhou-based carrier reported a fleet of 972 aircraft and 174 million passengers carried in 2025.

Shanghai – September 25, 2026 -- IASO Biotechnology reported an 88.9% objective response rate for its dual-targeted CAR-T therapy RD140 in a first-in-human Phase 1 trial of nine heavily pretreated multiple myeloma and plasma cell leukemia patients, with the response rate reaching 100% in the higher-dose cohort.

Shanghai – September 25, 2026 -- A retrospective analysis of 102 multiple myeloma patients treated with IASO Bio's FUCASO CAR-T therapy found that patients maintaining sustained minimal residual disease (MRD) negativity showed a median CAR-T cell persistence of 463 days, compared with 272 days in patients who experienced MRD conversion — a gap of roughly 191 days. The data, drawn from the pivotal FUMANBA-1 registration study, were presented as a poster (Abstract No. PA-469) at the 2026 International Myeloma Society Annual Meeting.